A pilot study evaluated a two-stage screening approach to identify psychologic distress in men with prostate carcinoma. The study involved 121 patients who completed two self-report measures: the Hospital Anxiety and Depression Scale (HADS) and the Distress Thermometer. Patients scoring above cutoffs (HADS ≥15, Thermometer ≥5) were referred to a psychiatric liaison for evaluation. Compliance was high, with 77% of patients completing the questionnaires. Thirty-one percent of evaluable patients were referred, and 17 were evaluated. Eight of these 17 met DSM-IV criteria for a psychiatric disorder. The study found that older men were reluctant to agree to evaluation and treatment, highlighting the need for further research to identify barriers to psychologic care. The study also noted that many prostate carcinoma patients experience significant psychologic distress due to the disease and its treatment, including anxiety, depression, and other symptoms. The use of self-rating questionnaires is a feasible and effective method for rapid screening, as they are inexpensive, rapid, and noninvasive. The study suggests that future research should focus on improving identification of distressed patients and ensuring they receive appropriate care. The results indicate that a two-stage screening approach is acceptable for identifying distress in prostate carcinoma patients, although further testing is needed to validate its effectiveness. The study also highlights the importance of addressing psychologic needs in cancer patients, as they are often overlooked. The findings emphasize the need for improved screening and intervention strategies to support patients and their families.A pilot study evaluated a two-stage screening approach to identify psychologic distress in men with prostate carcinoma. The study involved 121 patients who completed two self-report measures: the Hospital Anxiety and Depression Scale (HADS) and the Distress Thermometer. Patients scoring above cutoffs (HADS ≥15, Thermometer ≥5) were referred to a psychiatric liaison for evaluation. Compliance was high, with 77% of patients completing the questionnaires. Thirty-one percent of evaluable patients were referred, and 17 were evaluated. Eight of these 17 met DSM-IV criteria for a psychiatric disorder. The study found that older men were reluctant to agree to evaluation and treatment, highlighting the need for further research to identify barriers to psychologic care. The study also noted that many prostate carcinoma patients experience significant psychologic distress due to the disease and its treatment, including anxiety, depression, and other symptoms. The use of self-rating questionnaires is a feasible and effective method for rapid screening, as they are inexpensive, rapid, and noninvasive. The study suggests that future research should focus on improving identification of distressed patients and ensuring they receive appropriate care. The results indicate that a two-stage screening approach is acceptable for identifying distress in prostate carcinoma patients, although further testing is needed to validate its effectiveness. The study also highlights the importance of addressing psychologic needs in cancer patients, as they are often overlooked. The findings emphasize the need for improved screening and intervention strategies to support patients and their families.